161 related articles for article (PubMed ID: 11358078)
1. Applications of magnetic resonance spectroscopy to chronic liver disease.
Taylor-Robinson SD
Clin Med (Lond); 2001; 1(1):54-60. PubMed ID: 11358078
[TBL] [Abstract][Full Text] [Related]
2. Development and applications of in vivo clinical magnetic resonance spectroscopy.
Cox IJ
Prog Biophys Mol Biol; 1996; 65(1-2):45-81. PubMed ID: 9029941
[TBL] [Abstract][Full Text] [Related]
3. RETRACTED ARTICLE: Diagnosis of rejection after liver transplantation: use of phosphorus-31 magnetic resonance spectroscopy ((31)P-MRS).
Jiang T; Liu S; Xiao X; Tao X; Liu G; Wang J
Abdom Imaging; 2012 Oct; 37(5):788-94. PubMed ID: 23166917
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications.
Khan SA; Cox IJ; Hamilton G; Thomas HC; Taylor-Robinson SD
Liver Int; 2005 Apr; 25(2):273-81. PubMed ID: 15780050
[TBL] [Abstract][Full Text] [Related]
5. Viability assessment of magnetic resonance spectroscopy for the detection of minimal hepatic encephalopathy severity.
Meng LP; Chen YC; Li YH; Zhu JS; Ye JL
Eur J Radiol; 2015 Oct; 84(10):2019-23. PubMed ID: 26170124
[TBL] [Abstract][Full Text] [Related]
6. Magnetic Resonance Spectroscopy: Principles and Techniques: Lessons for Clinicians.
Tognarelli JM; Dawood M; Shariff MI; Grover VP; Crossey MM; Cox IJ; Taylor-Robinson SD; McPhail MJ
J Clin Exp Hepatol; 2015 Dec; 5(4):320-8. PubMed ID: 26900274
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities of the liver evaluated by 31P MRS.
Meyerhoff DJ; Karczmar GS; Weiner MW
Invest Radiol; 1989 Dec; 24(12):980-4. PubMed ID: 2606636
[TBL] [Abstract][Full Text] [Related]
8. MR imaging and spectroscopy of the basal ganglia in chronic liver disease: correlation of T1-weighted contrast measurements with abnormalities in proton and phosphorus-31 MR spectra.
Taylor-Robinson SD; Sargentoni J; Oatridge A; Bryant DJ; Hajnal JV; Marcus CD; Seery JP; Hodgson HJ; deSouza NM
Metab Brain Dis; 1996 Sep; 11(3):249-68. PubMed ID: 8869945
[TBL] [Abstract][Full Text] [Related]
9. Hepatic 31P MRS in rat models of chronic liver disease: assessing the extent and progression of disease.
Corbin IR; Buist R; Peeling J; Zhang M; Uhanova J; Minuk GY
Gut; 2003 Jul; 52(7):1046-53. PubMed ID: 12801965
[TBL] [Abstract][Full Text] [Related]
10. Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy.
Grover VP; Dresner MA; Forton DM; Counsell S; Larkman DJ; Patel N; Thomas HC; Taylor-Robinson SD
World J Gastroenterol; 2006 May; 12(19):2969-78. PubMed ID: 16718775
[TBL] [Abstract][Full Text] [Related]
11. Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease.
Cox IJ; Sharif A; Cobbold JF; Thomas HC; Taylor-Robinson SD
World J Gastroenterol; 2006 Aug; 12(30):4773-83. PubMed ID: 16937457
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve.
Lee JH; Seo DW; Lee YS; Kim ST; Mun CW; Lim TH; Min YI; Suh DJ
Am J Gastroenterol; 1999 Aug; 94(8):2206-13. PubMed ID: 10445551
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance spectroscopy in the study of hyperammonemia and hepatic encephalopathy.
Kanamori K; Bluml S; Ross B
Adv Exp Med Biol; 1997; 420():185-94. PubMed ID: 9286434
[No Abstract] [Full Text] [Related]
14. Minimal hepatic encephalopathy in patients with liver cirrhosis: magnetic resonance spectroscopic brain findings versus neuropsychological changes.
Hassan EA; Abd El-Rehim AS; Seifeldein GS; Shehata GA
Arab J Gastroenterol; 2014; 15(3-4):108-13. PubMed ID: 25459346
[TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopy in portal-systemic encephalopathy.
Köstler H
Metab Brain Dis; 1998 Dec; 13(4):291-301. PubMed ID: 10206821
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer.
Dagnelie PC; Leij-Halfwerk S
World J Gastroenterol; 2010 Apr; 16(13):1577-86. PubMed ID: 20355236
[TBL] [Abstract][Full Text] [Related]
17. Does magnetic resonance spectroscopy identify patients with minimal hepatic encephalopathy?
Ciećko-Michalska I; Dziedzic T; Banyś R; Senderecka M; Binder M; Wyczesany M; Szewczyk J; Wójcik J; Słowik A; Mach T
Neurol Neurochir Pol; 2012; 46(5):436-42. PubMed ID: 23161187
[TBL] [Abstract][Full Text] [Related]
18. In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts.
Taylor-Robinson SD; Sargentoni J; Bell JD; Thomas EL; Marcus CD; Changani KK; Saeed N; Hodgson HJ; Davidson BR; Burroughs AK; Rolles K; Foster CS; Cox IJ
Gut; 1998 May; 42(5):735-43. PubMed ID: 9659173
[TBL] [Abstract][Full Text] [Related]
19. Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathy.
Guevara M; Baccaro ME; Gómez-Ansón B; Frisoni G; Testa C; Torre A; Molinuevo JL; Rami L; Pereira G; Sotil EU; Córdoba J; Arroyo V; Ginès P
J Hepatol; 2011 Sep; 55(3):564-573. PubMed ID: 21163310
[TBL] [Abstract][Full Text] [Related]
20. Minimal hepatic encephalopathy diagnosis by magnetic resonance spectroscopy. A case report.
Scheau C; Bădărău AI; Gherguş AE; Popa GA; Lupescu IG
J Gastrointestin Liver Dis; 2013 Dec; 22(4):455-9. PubMed ID: 24369330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
